Filter by: Subject

Filter by: Subject

Results Per Page:

Patients (14)
SDG-03: Good health and well-being (3)
Coronavirus disease 2019 (COVID-19) (2)
COVID-19 pandemic (2)
Human immunodeficiency virus (HIV) (2)
Infection (2)
South Africa (SA) (2)
Treatment (2)
Anti CTLA 4 (1)
Anti-PD 1 (1)
Bacterial cause (1)
Basal cell carcinoma (BCC) (1)
Biological promise (1)
Biomakers (1)
Bogus operators (1)
Checkpoint inhibitors (1)
Clinics (1)
Colitis (1)
Community-acquired pneumonia (CAP) (1)
Complete response rate (CRR) (1)
Cotinine in serum (1)
Health sciences article SDG-03 (1)
Highly active antiretroviral therapy (HAART) (1)
HIV-1 (1)
Humoral modulators of immune suppressor cells (1)
Immune related adverse effects (1)
Intestinal fatty acid-binding protein (1)
Intestinal fatty acid-binding protein (I-FABP) (1)
Legal consequences (1)
Legionella (1)
Legionnaires’ disease (1)
LPS-binding protein (LBP) (1)
Management plan (1)
Medical research (1)
Medical therapy (1)
Melamona (1)
Microbial lipopolysaccharides (LPS) (1)
Misconceptions (1)
Multiple organ dysfunction (1)
Occurrence (1)
Pneumococcal infections (1)
Pneumonia (1)
Pneumonitis (1)
Pulmonary surfactant protein D (SP-D) (1)
Recognition of sepsis (1)
Respiratory failure (1)
Respiratory illness (1)
Rheumatoid arthritis (RA) (1)
Risk factors (1)
SARS-CoV-2 Omicron variant (B.1.1.529) (1)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (1)
Sipke (1)
Stem cell therapy (1)
Stem cell tourism (1)
Stem cell treatments (1)
Stem cells (1)
Systemic illness (1)
Systemic soluble immune checkpoints (sICPs) (1)
Talimogene laherparepvec (T-VEC) (1)
Therapies (1)